Rotary seals, silicone materials, and medical-device applications account for leading shares as manufacturers prioritize low-friction performance, sterilization resistance, traceability, and controlled supplier qualification

Rockville, Maryland — September 16, 2026 — — The global medical and pharmaceutical dynamic sealing solutions market is projected to expand from USD 5.3 billion in 2026 to USD 10.8 billion by 2036, representing a 7.4% CAGR during the forecast period, according to a new report by Fact.MR. The market was valued at USD 4.9 billion in 2025, with an absolute opportunity of approximately USD 5.5 billion expected between 2026 and 2036.

Demand is being supported by the growing use of moving fluid-control and actuation interfaces in medical devices, pharmaceutical processing equipment, drug-delivery systems, and diagnostic equipment. These applications increasingly require sealing components that can maintain leakage control, dosing accuracy, pressure stability, and service life across repeated operating cycles.

Get detailed market forecasts, competitive benchmarking, and pricing trends: https://www.factmr.com/connectus/sample?flag=S&rep_id=15909

Medical Devices Remain a Major Demand Center

Medical devices are projected to account for 39% of the market in 2026, making the application segment an important source of demand. Infusion pumps, respiratory equipment, diagnostic platforms, and compact electromechanical systems use dynamic seals around pistons, shafts, valves, actuators, and other moving interfaces.

Medical device manufacturers are expected to represent 43% of end-user demand in 2026. Sealing components are frequently qualified during the device-design stage, meaning changes in material, geometry, tooling, surface finish, or supplier can require additional validation and documentation.

This has increased the importance of suppliers that can provide application-specific engineering alongside controlled manufacturing and traceability.

Rotary Seals and Silicone Lead Key Segments

Rotary seals are forecast to hold a 33% share of the market in 2026. Their use across pumps, drives, filling equipment, compressors, and other systems requiring shaft movement supports continued demand.

By material, silicone is expected to account for 36% share. Medical-grade silicone and liquid silicone rubber are used in applications where flexibility, precision molding, and compatibility with sterilized fluid-handling environments are required.

Direct sales are also projected to remain the leading distribution channel, with an estimated 48% share in 2026. OEM supply agreements and long-term contracts are particularly relevant because dynamic sealing performance depends on factors including geometry, operating cycles, lubrication, surface finish, pressure, temperature, and sterilization exposure.

Qualification and Regulatory Requirements Shape Purchasing

The market is not driven solely by component availability. Medical and pharmaceutical manufacturers must often evaluate sealing materials against application-specific requirements involving friction, wear, chemical compatibility, sterilization, extractables, and supplier change control.

For pharmaceutical equipment, repeated cleaning and sterilization cycles create additional requirements for seals used around filling systems, bioreactors, pumps, and other processing interfaces. Medical-device manufacturers likewise require controlled documentation because a sealing component can influence leakage, pressure behavior, dosing performance, and product reliability.

Fact.MR analyst S.N. Jha, Principal Consultant, notes:

“Dynamic seals are small components with system-level consequences. Buyers do not approve a seal on material name alone; they evaluate geometry, friction, wear, sterilization exposure, extractables, assembly controls and supplier change discipline as one risk package.”

The report identifies supplier qualification, material compatibility, documented performance, and application engineering as important considerations for participants seeking recurring OEM programs.

Regional Outlook

South Korea records the highest listed country growth rate in the Fact.MR assessment, with the market projected to expand at an 8.18% CAGR from 2026 to 2036. The United States follows at 7.83%, while Canada is projected at 7.47%.

The United Kingdom is forecast to grow at 7.22%, Australia at 7.16%, Germany at 7.02%, and Japan at 6.66% during the same period. Regional demand reflects differences in medical-device production, pharmaceutical manufacturing, equipment engineering, supplier qualification practices, and regulatory requirements.

Competitive Landscape

The competitive environment includes sealing and engineered-component companies serving medical-device, pharmaceutical, and life-science applications. Companies profiled in the report include Trelleborg AB, Freudenberg Sealing Technologies, Parker Hannifin Corporation, Saint-Gobain S.A., Datwyler Holding Inc., Bal Seal Engineering, Inc., Garlock Sealing Technologies, Precision Associates, Inc., James Walker Group Ltd., and ERIKS N.V.

Competition is shaped by product development capabilities, material expertise, clean manufacturing, application engineering, qualification support, supply consistency, and change-control processes rather than component availability alone.

Unlock 360° insights for strategic decision making and investment planning: https://www.factmr.com/report/medical-and-pharmaceutical-dynamic-sealing-solutions-market

Market Scope

The Fact.MR report covers dynamic sealing solutions used to contain fluids or gases across moving shafts, rods, pistons, oscillating interfaces, and pressure-cycling boundaries in medical and pharmaceutical systems.

The study analyzes the market by product type, material, application, end user, distribution channel, and region, covering rotary seals, reciprocating seals, O-rings and elastomeric seals, diaphragms, bellows, custom dynamic seals, silicone, PTFE, EPDM, FKM, PEEK, thermoplastic elastomers, medical devices, pharmaceutical manufacturing equipment, drug-delivery systems, and diagnostic and laboratory equipment.

Explore More Related Studies Published by Fact.MR Research

Gaucher Disease Drugs Market- https://www.factmr.com/report/gaucher-disease-drugs-market

OTC Dry Eye Drops Market- https://www.factmr.com/report/otc-dry-eye-drops-market

Rat Mouse Model Market- https://www.factmr.com/report/rat-mouse-model-market

Vitamin D Therapy Market- https://www.factmr.com/report/vitamin-d-therapy-market

X-Ray Irradiation Market- https://www.factmr.com/report/x-ray-irradiation-market

About Fact.MR

Fact.MR is a market research and consulting firm providing industry intelligence across healthcare, food and nutrition, technology, chemicals, and other high-growth sectors. Its research combines secondary research, primary interviews, company analysis, market sizing, and forecasting to support strategic business decisions.

Media Contact

Fact.MR
Email: [email protected]
Website: https://www.factmr.com/